Prevention of neonatal sepsis

Clinics in Perinatology

Volumn 32, Issue 3, 2005, Pages 601-615

  Schrag, Stephanie ^a   Schuchat, Anne ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CEFAZOLIN; CHLORHEXIDINE; CLINDAMYCIN; CORTICOSTEROID; DISINFECTANT AGENT; ERYTHROMYCIN; PENICILLIN G; POLYSACCHARIDE VACCINE; STREPTOCOCCUS VACCINE; VANCOMYCIN;

ANAPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG AMNION FLUID LEVEL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HOSPITAL INFECTION; HUMAN; IMMUNOGENICITY; INCIDENCE; INFANT MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN DEATH; NEWBORN SEPSIS; NONHUMAN; PENICILLIN ALLERGY; PENICILLIN RESISTANCE; PNEUMONIA; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERAL INFECTION; REVIEW; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; UNITED STATES;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; FEMALE; HUMANS; INCIDENCE; INFANT MORTALITY; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; UNITED STATES;

EID: 23444443685     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2005.05.005     Document Type: Review

References (55)

1. R. Black, S. Morris, and J. Boyce Where and why are 10 million children dying every year? Lancet 361 2003 2226 2234
2. B. Stoll Neonatal infections: a global perspective J. Remington J. Klein Infectious diseases of the fetus and newborn infant 5th edition 2001 W.B. Saunders Philadelphia 139 168
3. R. Freedman, D. Ingram, and I. Gross A half century of neonatal sepsis at Yale, 1928 to 1978 Am J Dis Child 135 1981 140 144
4. A. Schuchat, S.S. Zywicki, and M.J. Dinsmoor Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study Pediatrics 105 1 2000 21 26
5. R.S. Baltimore, S.M. Huie, and J.I. Meek Early-onset neonatal sepsis in the era of group B streptococcal prevention Pediatrics 108 5 2001 1094 1098
6. T.B. Hyde, T.M. Hilger, and A. Reingold Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta Pediatrics 110 4 2002 690 695
7. B.J. Stoll, N. Hansen, and A.A. Fanaroff Changes in pathogens causing early-onset sepsis in very-low-birthweight infants N Engl J Med 347 2002 240 247
8. S.J. Schrag, S. Zywicki, and M.M. Farley Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis N Engl J Med 342 2000 15 20
9. Centers for Disease Control and Prevention Diminishing racial disparities in early-onset neonatal group B streptococcal disease - United States, 2000-2003 MMWR 53 23 2004 502 505
10. M.R. Moore, S.J. Schrag, and A. Schuchat Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis Lancet Infect Dis 3 4 2003 201 213
11. S. Lukacs, K. Schoendorf, and A. Schuchat Trends in sepsis-related neonatal mortality in the United States, 1985-98 Pediatr Inf Dis J 23 2004 599 603
12. Lukacs S., Schuchat A., Schoendorf K.C. National estimates of newborn sepsis: United States, 1990-2002. Presented at the Society for Pediatric and Perinatal Epidemiologic Research. Salt Lake City, June 14-15, 2004
13. A. Schuchat, K. Deaver-Robinson, and B.D. Plikaytis Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease Pediatr Inf Dis J 13 1994 623 629
14. A. Schuchat, and J.D. Wenger Epidemiology of group B streptococcal disease: risk factors, prevention strategies, vaccine development Epidemiol Rev 16 2 1994 374 402
15. K.M. Boyer, C.A. Gadzala, and L.I. Burd Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale J Infect Dis 148 1983 795 801
16. M. Yancey, P. Duff, and P. Kubilis Risk factors for neonatal sepsis Obstet Gynecol 87 1996 188 194
17. S.J. Schrag, E.R. Zell, and R. Lynfield A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates N Engl J Med 347 2002 233 239
18. A. Schuchat, M. Oxtoby, and S. Cochi Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta J Infect Dis 162 1990 672 677
19. J. Martius, T. Roos, and B. Gora Risk factors associated with early-onset sepsis in premature infants Eur J Obstet Gynecol Reprod Biol 85 1999 151 158
20. K.M. Boyer, and S.P. Gotoff Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis N Engl J Med 314 26 1986 1665 1669
21. N. Tuppurainen, and M. Hallman Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients Obstet Gynecol 73 1989 583 587
22. R. Matorras, A. Garcia-Perea, and F. Omenaca Intrapartum chemoprophylaxis of early-onset group B streptococcal disease Eur J Obstet Gynecol Reprod Biol 40 1991 57 62
23. S.M. Garland, and J.R. Fliegner Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis Aust NZ J Obstet Gynecol 31 2 1991 119 122
24. D.J. Rouse, R.L. Goldenberg, and S.P. Cliver Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis Obstet Gynecol 83 1994 483 494
25. J.C. Mohle-Boetani, A. Schuchat, and B.D. Plikaytis Comparison of prevention strategies for neonatal group B streptococcal infection: a population-based economic approach JAMA 270 12 1993 1442 1448
26. J.C. Mohle-Boetani, T.A. Lieu, and G.T. Ray Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics Pediatrics 103 4 1999 703 710
27. Centers for Disease Control and Prevention Prevention of perinatal group B streptococcal disease: a public health perspective MMWR Morb Mortal Wkly Rep 45 RR-7 1996 1 24
28. Centers for Disease Control and Prevention Early-onset group B streptococcal disease, United States, 1998-1999 MMWR Morb Mortal Wkly Rep 49 35 2000 793 796
29. Centers for Disease Control and Prevention Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC MMWR Morb Mortal Wkly Rep 51 RR-11 2002 1 22
30. Committee on Obstetric Practice American College of Obstetricians and Gynecologists Prevention of early-onset group B streptococcal disease in newborns 2002 American College of Obstetricians and Gynecologists Washington, DC
31. J.D. Siegel, G.H.J. McCracken, and N. Threlkeld Single dose penicillin prophylaxis against neonatal group B streptococcal infections: a controlled trial in 18,738 newborn infants N Engl J Med 303 1980 769 775
32. J.D. Siegel, G.H.J. McCracken, and N. Threlkeld Single-dose penicillin prophylaxis of neonatal group B streptococcal disease Lancet i 1982 1426 1430
33. S.P. Pyati, R.S. Pildes, and N.M. Jacobs Penicillin in infants weighing two kilograms or less with early-onset group B streptococcal disease N Engl J Med 308 1983 1383 1389
34. D. Patel, P. Rhodes, and M. LeBlanc Role of postnatal penicillin prophylaxis in prevention of neonatal group B streptococcus infection Acta Paediatr 88 1999 874 879
35. G.D. Wendel, K.J. Leveno, and P.J. Sanchez Prevention of neonatal group B streptococcal disease: a combined intrapartum and neonatal protocol Am J Obstet Gynecol 186 4 2002 618 626
36. D.L. Kasper, L.C. Paoletti, and M.R. Wessels Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine J Clin Invest 98 1996 2308 2314
37. C. Baker, M. Rench, and P. McInnes Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine Vaccine 21 2003 3468 3472
38. C.J. Baker, and M.S. Edwards Group B streptococcal conjugate vaccines Arch Dis Child 88 5 2003 375 378
39. Hunter S.K., Andracki M. Univalent GBS vaccine utilizing C5A peptidase encapsulated within biodegradable polymeric microspheres. Presented at the Infectious Diseases Society of Obstetricians and Gynecologists. San Diego, August 5-7, 2004
40. D. Isaacs, and J.A. Royle Intrapartum antibiotics and early onset neonatal sepsis caused by group B streptococcus and by other organisms in Australia Pediatr Inf Dis J 18 1999 524 528
41. T.B. Hyde, T.M. Hilger, and A. Reingold Trends in the incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta Pediatrics 110 4 2002 690 695
42. B.M. Mercer, M. Miodovnik, and G. Thurnau Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: a randomized controlled trial JAMA 278 12 1997 989 995
43. S.L. Kenyon, D.J. Taylor, and W. Tarnow-Mordi ORACLE Collaborative Group: broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial Lancet 357 2001 979 988
44. S.L. Kenyon, D.J. Taylor, and W. Tarnow-Mordi ORACLE Collaborative Group: broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial Lancet 357 9261 2001 989 994
45. B. Mercer, R. Goldenberg, and A. Das What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes Semin Perinatol 27 3 2003 217 230
46. T.E. Taha, R.J. Biggar, and R.L. Broadhead Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity in Malawi: clinical trial BMJ 315 1997 216 220
47. B. Stray-Pedersen, T. Bergan, and A. Hafstad Vaginal disinfection with chlorhexidine during childbirth Int J Antimicrob Agents 12 3 1999 245 251
48. L.G. Burman, P. Christensen, and K. Christensen Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour Lancet 340 1992 65 69
49. D.J. Rouse, J.C. Hauth, and W.W. Andrews Chlorhexidine vaginal irrigation for the prevention of peripartal infection: a placebo-controlled randomized clinical trial Am J Obstet Gynecol 176 1997 617 622
50. F. Facchinetti, F. Piccinini, and B. Mordini Chlorhexidine vaginal flushings versus systemic ampicillin in the prevention of vertical transmission of neonatal group B streptococcus, at term J Matern Fetal Neonatal Med 11 2002 84 88
51. R.L. Davis, M.B. Hasselquist, and V. Cardenas Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization Am J Obstet Gynecol 184 4 2001 603 610
52. J.J. Andrews, D.J. Diekema, and S.K. Hunter Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western hemisphere Am J Obstet Gynecol 183 2000 859 862
53. M. Fernandez, M.E. Hickman, and C.J. Baker Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis Antimicrob Agents Chemother 42 1998 1517 1519
54. J. Heelan, M. Hasenbein, and A. McAdam Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin J Clin Microbiol 42 2004 1263 1264
55. A. Sinha, D. Yokoe, and R. Platt Intrapartum antibiotics and neonatal invasive infections caused by organisms other than group B streptococcus J Pediatr 142 5 2003 492 497